首次非诱发性癫痫发作后的抗癫痫药物治疗:一项决策分析
该决策分析构建模拟临床试验(马尔可夫决策模型),比较成人首次非诱发性癫痫发作后立即与延迟抗癫痫药物治疗的预期质量调整生命年(QALY)。结果显示,对于10年复发风险52.0%的中度风险患者,立即治疗使QALY最大化;使延迟治疗成为优选需10年复发率≤38.0%等不现实条件。结论认为立即治疗在广泛临床相关变量范围内更优,且支持治疗的10年复发率阈值38.0%远低于当前癫痫定义所用的60%。
要点
- 成人首次非诱发性发作后,立即抗癫痫药物治疗在广泛临床相关变量范围内优于延迟治疗。
- 对于10年复发风险52.0%的中度风险患者,立即治疗使QALY最大化。
- 使延迟治疗成为优选需10年复发率≤38.0%、复发致QOL下降≤0.06、AED降低复发率疗效≤16.3%等不现实条件。
核心结论
- 模型确定,在广泛且临床相关的变量范围内,成人首次癫痫发作后立即AED治疗优于延迟治疗。
- 分析提示,支持AED治疗的10年癫痫复发率阈值38.0%远低于当前癫痫定义所用的60%阈值。
研究设计与样本
- 构建模拟临床试验(马尔可夫决策模型),比较成人首次非诱发性癫痫发作后立即与延迟AED治疗的预期QALY。
- 考虑三个基础病例,代表癫痫复发风险及发作对生活质量影响程度不同的患者。
- 进行队列模拟以确定哪种治疗策略最大化患者预期QALY。
主要发现
- 对于10年复发风险52.0%的中度风险患者,立即AED治疗相比延迟治疗使QALY最大化。
- 敏感性分析显示,要使优选变为延迟AED治疗,关键临床指标需达到不现实的值:10年癫痫复发率≤38.0%、复发发作所致QOL下降≤0.06、AED降低复发率的疗效≤16.3%。
关键数值与推荐
- 中度复发风险患者的10年复发率为52.0%。
- 使延迟治疗成为优选的10年癫痫复发率阈值为≤38.0%。
- 使延迟治疗成为优选的QOL下降阈值为≤0.06。
- 使延迟治疗成为优选的AED降低复发率疗效阈值为≤16.3%。
- 当前癫痫定义所用的10年复发率阈值为60%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the expected quality-adjusted life-years (QALYs) in adult patients undergoing immediate vs deferred antiepileptic drug (AED) treatment after a first unprovoked seizure. METHODS: We constructed a simulated clinical trial (Markov decision model) to compare immediate vs deferred AED treatment after a first unprovoked seizure in adults. Three base cases were considered, representing patients with varying degrees of seizure recurrence risk and effect of seizures on quality of life (QOL). Cohort simulation was performed to determine which treatment strategy would maximize the patient's expected QALYs. Sensitivity analyses were guided by clinical data to define decision thresholds across plausible measurement ranges, including seizure recurrence rate, effect of seizure recurrence on QOL, and efficacy of AEDs. RESULTS: For patients with a moderate risk of recurrent seizures (52.0% over 10 years after first seizure), immediate AED treatment maximized QALYs compared to deferred treatment. Sensitivity analyses showed that for the preferred choice to change to deferred AED treatment, key clinical measures needed to reach implausible values were 10-year seizure recurrence rate ≤38.0%, QOL reduction with recurrent seizures ≤0.06, and efficacy of AEDs on lowering seizure recurrence rate ≤16.3%. CONCLUSION: Our model determined that immediate AED treatment is preferable to deferred treatment in adult first-seizure patients over a wide and clinically relevant range of variables. Furthermore, our analysis suggests that the 10-year seizure recurrence rate that justifies AED treatment (38.0%) is substantially lower than the 60% threshold used in the current definition of epilepsy.
引用
- Bao EL, Chao LY, Ni P, et al. Antiepileptic drug treatment after an unprovoked first seizure: A decision analysis. Neurology. 2018. PMID: 30209239. doi:10.1212/WNL.0000000000006319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。